
    
      This trial is a prospective, randomized, open label, two arm designed multi-center trial.
      When diagnostic coronary angiogram shows that the target lesion is intermediate stenosis,
      IVUS and/or FFR will be performed in order to decide PCI or defer by 1:1 randomization. The
      patients would be followed up to 2 years clinically.
    
  